Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Effects of Lifitegrast and Tocopherol Combination Eye Drops in an Experimental Dry Eye Mouse Model
Author Affiliations & Notes
  • Hyun Jee Kim
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
    Medical school, Chonnam National University, Gwangju, Jeollanam-do, Korea (the Republic of)
  • Jin Hui
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Hee Su Yoon
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Enying Jiang
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Jingting Liu
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Ji Suk Choi
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Jayoung Moon
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Hyeon-Jeong Yoon
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Kyung Chul Yoon
    Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Hyun Jee Kim None; Jin Hui None; Hee Su Yoon None; Enying Jiang None; Jingting Liu None; Ji Suk Choi None; Jayoung Moon None; Hyeon-Jeong Yoon None; Kyung Chul Yoon None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2968. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyun Jee Kim, Jin Hui, Hee Su Yoon, Enying Jiang, Jingting Liu, Ji Suk Choi, Jayoung Moon, Hyeon-Jeong Yoon, Kyung Chul Yoon; Effects of Lifitegrast and Tocopherol Combination Eye Drops in an Experimental Dry Eye Mouse Model. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2968.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the effects of combination eye drops containing lifitegrast (LF) with anti-inflammatory properties and tocopherol (TO) with antioxidant effects in an experimental dry eye (EDE) mice model

Methods : EDE was induced in 8-week-old C57BL/6 mice by desiccating stress and injection of scopolamine. The mice were divided into control, EDE, 0.05% cyclosporine (CsA) eye drop, 5% LF eye drop, 10% LF eye drop, and 10% LF+TO eye drop groups. Eye drops 0.05% CsA and 5% LF were administered twice daily, while 10% LF and 10% LF+TO were administered once daily. Tear volume, tear-film break-up time (TBUT), corneal staining scores (CSS), and the tear lipid layer were assessed on days 7 and 14. Additionally, immune T-cell counts and reactive oxygen species (ROS) were evaluated through flow cytometry on day 14.

Results : Tear volume and TBUT on days 7 and 14 were higher in all treatment groups (0.05% CsA, 5% LF, 10% LF, 10% LF+TO) than in the EDE group. CSS showed a significant decrease in the 10% LF+TO group compared to not only the EDE group but also the 5% LF group after 14 days of treatment. Tear lipid layer scores significantly improved in all treatment groups on day 14 compared to that in the EDE group, and the 10% LF+TO group showed improvement compared to the 5% LF group on days 7 and 14. The conjunctival ROS and CD4+IFN-γ+T cells were significantly decreased in the 10% LF+TO group compared to that in the EDE, 0.05% CsA, 5% LF, and 10% LF groups.

Conclusions : In the EDE mice model, the 10% LF+TO combination eye drop improved tear volume and ocular surface findings. Additionally, compared to conventional LF eye drops, it demonstrated effectiveness in stabilizing oxidative damage and the tear lipid layer.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×